Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity

[1]  F. Barkhof,et al.  Investigating Functional Network Abnormalities and Associations With Disability in Multiple Sclerosis , 2022, Neurology.

[2]  F. Barkhof,et al.  Longitudinal Network Changes and Conversion to Cognitive Impairment in Multiple Sclerosis , 2021, Neurology.

[3]  A. Feinstein,et al.  Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis. , 2019, Brain : a journal of neurology.

[4]  De Giglio Laura,et al.  The Role of fMRI in the Assessment of Neuroplasticity in MS: A Systematic Review , 2018, Neural plasticity.

[5]  L. Westlye,et al.  Symptoms of fatigue and depression is reflected in altered default mode network connectivity in multiple sclerosis , 2018, bioRxiv.

[6]  M. Filippi,et al.  Abnormal functional connectivity of thalamic sub-regions contributes to fatigue in multiple sclerosis , 2018, Multiple sclerosis.

[7]  S. Whitfield-Gabrieli,et al.  Understanding marijuana's effects on functional connectivity of the default mode network in patients with schizophrenia and co-occurring cannabis use disorder: A pilot investigation , 2017, Schizophrenia Research.

[8]  F. Esposito,et al.  Fatigue in multiple sclerosis: The contribution of resting-state functional connectivity reorganization , 2018, Multiple sclerosis.

[9]  D. Centonze,et al.  Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity , 2016, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  W. Staines,et al.  Multiple sclerosis, cannabis, and cognition: A structural MRI study , 2015, NeuroImage: Clinical.

[11]  F. Jacques.  Defining the clinical course of multiple sclerosis: The 2013 revisions , 2015, Neurology.

[12]  David M. Cole,et al.  Manipulating brain connectivity with δ9-tetrahydrocannabinol: A pharmacological resting state FMRI study , 2012, NeuroImage.

[13]  Susan L. Whitfield-Gabrieli,et al.  Conn: A Functional Connectivity Toolbox for Correlated and Anticorrelated Brain Networks , 2012, Brain Connect..

[14]  C. Pozzilli,et al.  A randomized, double‐blind, placebo‐controlled, parallel‐group, enriched‐design study of nabiximols * (Sativex®), as add‐on therapy, in subjects with refractory spasticity caused by multiple sclerosis , 2011, European journal of neurology.

[15]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[16]  F. Barkhof,et al.  Resting state networks change in clinically isolated syndrome. , 2010, Brain : a journal of neurology.

[17]  Jeih-San Liow,et al.  Imaging and Quantitation of Cannabinoid CB1 Receptors in Human and Monkey Brains Using 18F-Labeled Inverse Agonist Radioligands , 2010, Journal of Nuclear Medicine.

[18]  K. Hsu,et al.  Cannabinoid‐induced presynaptic inhibition at the primary afferent trigeminal synapse of juvenile rat brainstem slices , 2004, The Journal of physiology.

[19]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[20]  Gary H Glover,et al.  Estimating sample size in functional MRI (fMRI) neuroimaging studies: Statistical power analyses , 2002, Journal of Neuroscience Methods.

[21]  K. Hsu,et al.  Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons , 2001, The Journal of physiology.